Doctor profile · Federal record

Dr. Charles Sidwa, PA

Dermatology Physician (CMS: Physician Assistant) · Manahawkin, NJ

  • NPI 1295784734
  • Accepts Medicare
  • MIPS 100.0 / 100 · 2023
  • 27 yrs in practice
  • Male
  • Group practice
  • No sanctions

Practice & contact

NPPES Updated May 11, 2026
Primary practice
1322 Route 72 W, Suite 201
Manahawkin, NJ 08050
(800) 337-6663
Mailing address
1580 Lakewood RD Ste 16
Toms River, NJ 087553287

Credentials & registration

NPPES · NUCC
NPI registered
May 2006 — 20 yrs on file
Profile last updated
August 4, 2021
Year of graduation
1999 — 27 yrs since
Specialty taxonomy
207N00000X — NUCC code
State license (1)
New Jersey #25MP00052400

Federal sanctions & exclusions

OIG LEIE Updated May 11, 2026

No sanctions, exclusions or revocations on file

Checked against OIG LEIE on NPI 1295784734. Last verified May 11, 2026.

Medicare procedures · 2023

Top services delivered

CMS Provider Utilization
Total services
4,098
Distinct HCPCS
10
Medicare allowed
$224,875
HCPCS Description Services Patients Avg allowed
17003 Destruction of precancer skin growth, 2-14 growths 1,333 273 $6
99213 Established patient office or other outpatient visit, 20-29 minutes 903 565 $82
17000 Destruction of precancer skin growth, 1 growth 568 403 $51
11102 Biopsy of related skin growth, first growth 299 243 $90
99212 Established patient office or other outpatient visit, 10-19 minutes 273 216 $52
99203 New patient office or other outpatient visit, 30-44 minutes 178 178 $102
11103 Biopsy of related skin growth, each additional growth 98 65 $47
11301 Shaving of skin growth of body, arms, or legs, 0.6-1.0 cm 50 46 $106
96372 Injection of drug or substance under skin or into muscle 42 15 $13
99214 Established patient office or other outpatient visit, 30-39 minutes 41 35 $114

In context: peer comparison

Among 1 peers in Manahawkin Dermatology Physician, average services per provider: 170. This provider delivers 24× the peer median.

Open Payments

Industry payments received

CMS Open Payments
All-time total
$2,076
Transactions
130
Manufacturers
15
Payer (manufacturer) Industry Txns Amount
Abbvie INC. 24 $382.15
Lilly USA, LLC 20 $263.72
Novartis Pharmaceuticals Corporation 15 $257.98
Medimetriks Pharmaceuticals, INC. 1 $250.00
Leo Pharma INC. 27 $200.05
Genzyme Corporation 10 $142.25
Sun Pharmaceutical Industries INC. 7 $107.70
Amgen INC. 5 $83.79
Regeneron Healthcare Solutions, INC. 5 $81.33
Incyte Corporation 4 $64.86
Galderma Laboratories, L.P. 3 $46.92
Dermavant Sciences, INC. 3 $46.12
Pfizer INC. 3 $43.21
E.R. Squibb & Sons, L.L.C. 2 $28.77
Mayne Pharma Commercial LLC 1 $23.15

By nature of payment

Food and Beverage
$1,826
Consulting Fee
$250

Medicare Part D · 2023

Top prescriptions

CMS Part D Prescriber
Total claims
1,623
Patients
976
Total drug cost
$581,667
Drug Type Claims Patients Total cost
Triamcinolone Acetonide Generic 532 365 $4,222
Ketoconazole Generic 252 138 $4,609
Mometasone Furoate Generic 139 86 $3,742
Clobetasol Propionate Generic 137 78 $10,014
Doxycycline Hyclate Generic 106 52 $2,689
Fluorouracil Generic 75 63 $7,320
Dupixent Pen (Dupilumab) Brand 70 11 $248,362
Amoxicillin Generic 67 54 $165
Metronidazole Generic 65 41 $3,318
Clindamycin Phosphate Generic 52 28 $1,640

Frequently asked questions

Auto-generated from federal data
What is Dr. Charles Sidwa's medical specialty?
Dr. Charles Sidwa practices Dermatology Physician in Manahawkin, NJ.
Where does Dr. Charles Sidwa practice?
Dr. Charles Sidwa practices at 1322 Route 72 W, Manahawkin, NJ 08050. Office phone: 8003376663.
What is Dr. Charles Sidwa's NPI?
Dr. Charles Sidwa's National Provider Identifier (NPI) is 1295784734, issued by NPPES.
Does Dr. Charles Sidwa accept Medicare assignment?
Yes. Dr. Charles Sidwa accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Charles Sidwa commonly perform?
Top Medicare-reported procedures in 2023: Destruction of precancer skin growth, 2-14 growths (HCPCS 17003); Established patient office or other outpatient visit (HCPCS 99213); Destruction of precancer skin growth, 1 growth (HCPCS 17000). Source: CMS Medicare Physician & Other Practitioners file.